Mind Medicine (MindMed) Inc
NASDAQ:MNMD

Watchlist Manager
Mind Medicine (MindMed) Inc Logo
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Watchlist
Price: 7.32 USD 3.39%
Market Cap: 536.8m USD
Have any thoughts about
Mind Medicine (MindMed) Inc?
Write Note

Mind Medicine (MindMed) Inc
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Mind Medicine (MindMed) Inc
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Common Shares Outstanding
$81.6m
CAGR 3-Years
43%
CAGR 5-Years
190%
CAGR 10-Years
24%
Bausch Health Companies Inc
TSX:BHC
Common Shares Outstanding
$367.7m
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
1%
Canopy Growth Corp
TSX:WEED
Common Shares Outstanding
CA$93.9m
CAGR 3-Years
-38%
CAGR 5-Years
-23%
CAGR 10-Years
9%
Sundial Growers Inc
NASDAQ:SNDL
Common Shares Outstanding
CA$262.8m
CAGR 3-Years
42%
CAGR 5-Years
99%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Common Shares Outstanding
$382.3m
CAGR 3-Years
1%
CAGR 5-Years
2%
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
Common Shares Outstanding
$726.3m
CAGR 3-Years
3%
CAGR 5-Years
172%
CAGR 10-Years
N/A
No Stocks Found

Mind Medicine (MindMed) Inc
Glance View

Market Cap
536.8m USD
Industry
Pharmaceuticals

Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-05-04. The firm focuses on discovering, developing and deploying psychedelic-inspired medicines and therapies to address addiction and mental illness. The firm's commercial drug development programs includes lysergic acid diethylamide (LSD) experiential therapy, 18-methoxycoronaridine (18-MC) opioid withdrawal, LSD microdosing, methylenedioxymethamphetamine (MDMA), and dimethyltryptamine (DMT). The firm's subsidiaries include Mind Medicine, Inc., HealthMode, Inc., MindMed Pty Ltd. and MindMed GmbH.

MNMD Intrinsic Value
2.22 USD
Overvaluation 70%
Intrinsic Value
Price

See Also

What is Mind Medicine (MindMed) Inc's Common Shares Outstanding?
Common Shares Outstanding
81.6m USD

Based on the financial report for Sep 30, 2024, Mind Medicine (MindMed) Inc's Common Shares Outstanding amounts to 81.6m USD.

What is Mind Medicine (MindMed) Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
24%

Over the last year, the Common Shares Outstanding growth was 103%. The average annual Common Shares Outstanding growth rates for Mind Medicine (MindMed) Inc have been 43% over the past three years , 190% over the past five years , and 24% over the past ten years .

Back to Top